Printer-friendly version Send to friend
  • Increase
  • Decrease
  • Normal

Current Size: 100%

Changed date for BioGaia's Year-end report

BioGaia's Year-end report 2009 will be published on 22 February 2010 instead of on 18 February as was previous announced.

Latest press releases from BioGaia:
2009-12-08 BioGaia nominates two Executive Vice Presidents
2009-10-22 Interim report 1 January - 30 September 2009
2009-10-08 BioGaia agreement for Denmark

For additional information contact:
Peter Rothschild, President, telephone: +46 8 -555 293 00
Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products
with documented health benefits. The products are primarily based on the lactic acid
bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects.
The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list
of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com

View as pdf: 091209eng